Salesforce stock initiated at Hold by CLSA on growth concerns

This is fundamentally a proof issue, not a moat issue. CRM can remain a cash-generative franchise, but the stock is now hostage to whether AI is additive to top-line expansion or merely a narrative overlay on slower core seat growth; when that debate is unresolved, the multiple tends to compress even if margins stay high. The likely winners in enterprise software are the large platform vendors with cross-subsidized AI distribution and deeper workflow lock-in; the at-risk cohort is the standalone app layer that must show incremental monetization fast enough to justify premium durability.

Near term, this looks more like a valuation cap than a collapse: analyst dispersion suggests the market is already split, so incremental upside probably requires a measurable organic-growth inflection, not just more AI product announcements. The regional CIO spend split matters because CRM is more levered than MSFT to discretionary app budgets; US resilience helps, but softer Europe can still blunt the revenue mix over the next 1-2 quarters.

The contrarian view is that the stock may already be discounting a lot of this skepticism, so a small beat on billings or cRPO could force shorts to cover. What would invalidate the cautious setup is a quarter showing organic growth back above ~8% with evidence that AI attach is expanding deal size rather than substituting for legacy licenses; absent that, the path of least resistance is range-bound to lower over 1-3 months and a flatter multiple over 6-18 months.